Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Preferred Stock [Member] Redeemable Preferred Stock [Member]	Preferred Stock [Member] Series F Preferred Stock [Member]	Preferred Stock [Member] Series D Preferred Stock [Member]	Preferred Stock [Member] At the Market Offering Agreement [Member]	Preferred Stock [Member] Employees and Directors [Member]	Preferred Stock [Member] Director [Member]	Preferred Stock [Member]	Common Stock [Member] Series F Preferred Stock [Member]	[1]	Common Stock [Member] Series D Preferred Stock [Member]	[1]	Common Stock [Member] At the Market Offering Agreement [Member]	[1]	Common Stock [Member] Employees and Directors [Member]	[1]	Common Stock [Member] Director [Member]	[1]	Common Stock [Member]	[1]	Additional Paid-in Capital [Member] Series F Preferred Stock [Member]	Additional Paid-in Capital [Member] Series D Preferred Stock [Member]	Additional Paid-in Capital [Member] At the Market Offering Agreement [Member]	Additional Paid-in Capital [Member] Employees and Directors [Member]	Additional Paid-in Capital [Member] Director [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member] Series F Preferred Stock [Member]	Retained Earnings [Member] Series D Preferred Stock [Member]	Retained Earnings [Member] At the Market Offering Agreement [Member]	Retained Earnings [Member] Employees and Directors [Member]	Retained Earnings [Member] Director [Member]	Retained Earnings [Member]	Series F Preferred Stock [Member]	Series D Preferred Stock [Member]	The 2024 Warrant Reprice Transaction [Member]	At the Market Offering Agreement [Member]	Employees and Directors [Member]	Director [Member]	Total
Balance (in shares) at Dec. 31, 2024							1,000											977,000
Balance at Dec. 31, 2024							$ 6,000											$ 10,000							$ 183,312,000						$ (183,457,000)							$ (129,000)
Net income (loss)							$ 0											$ 0							0						7,670,000							7,670,000
Exercise of warrants (in shares)							0											186,000
Exercise of warrants							$ 0											$ 2,000							612,000						0							614,000
Stock-based compensation expense							$ 0											$ 0							2,000						0							2,000
Balance (in shares) at Mar. 31, 2025							1,000											1,163,000
Balance at Mar. 31, 2025							$ 6,000											$ 12,000							181,936,000						(175,787,000)							6,167,000
Repurchase of warrants							$ 0											$ 0							(1,990,000)						0							(1,990,000)
Balance (in shares) at Dec. 31, 2024							1,000											977,000
Balance at Dec. 31, 2024							$ 6,000											$ 10,000							183,312,000						(183,457,000)							(129,000)
Net income (loss)																																						4,455,000
Issuance of Common Stock in at the market offering, net																																$ 1,484,000
Balance (in shares) at Sep. 30, 2025	1,987,000						482,000											1,202,000
Balance at Sep. 30, 2025	$ 525,000						$ 3,792,000											$ 12,000							181,122,000						(183,817,000)							1,109,000
Deemed capital contribution pursuant to Series F Agreements																																						433,000
Balance (in shares) at Mar. 31, 2025							1,000											1,163,000
Balance at Mar. 31, 2025							$ 6,000											$ 12,000							181,936,000						(175,787,000)							6,167,000
Net income (loss)							$ 0											$ 0							0						(1,922,000)							(1,922,000)
Stock-based compensation expense					$ 0									$ 0									$ 1,000						$ 0							$ 1,000
Balance (in shares) at Jun. 30, 2025							1,000											1,164,000
Balance at Jun. 30, 2025							$ 6,000											$ 12,000							181,936,000						(177,709,000)							4,245,000
Repurchase of warrants							0											0							(1,000)						0							(1,000)
Vesting of director restricted stock awards (in shares)						0										1,000
Vesting of director restricted stock awards						$ 0										$ 0								$ 0						$ 0							$ 0
Net income (loss)							$ 0											$ 0							0						(1,293,000)							(1,293,000)
Exercise of warrants (in shares)							0											38,000
Exercise of warrants							$ 0											$ 0							237,000						0							237,000
Issuance of Common Stock in at the market offering, net (in shares)		1,987,000	481,000					0		0
Issuance of Common Stock in at the market offering, net		$ 525,000	$ 3,786,000					$ 0		$ 0											$ 0					$ 0	$ 0						$ 3,786,000
Balance (in shares) at Sep. 30, 2025	1,987,000						482,000											1,202,000
Balance at Sep. 30, 2025	$ 525,000						$ 3,792,000											$ 12,000							181,122,000						(183,817,000)							1,109,000
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs																				$ (1,484)												(1,484)
Deemed capital contribution pursuant to Series F Agreements																				433,000												433,000
Dividend paid							$ 0											$ 0							0						(4,815,000)							(4,815,000)
Balance (in shares) at Dec. 31, 2025	1,347,000						1,000											25,216,000
Balance at Dec. 31, 2025	$ 350,000						$ 6,000											$ 252,000							186,981,000						(819,054,000)							(631,815,000)
Net income (loss)							$ 0											$ 0							0						552,403,000							552,403,000
Redemption of Series F Preferred Stock (in shares)		(1,347,000)						0
Redemption of Series F Preferred Stock		$ (350,000)						$ 0												$ 0						$ 0						0
Conversion of Preferred Stock to common stock (in shares)							0											7,000
Conversion of Preferred Stock to common stock							$ 0											$ 0							128,000						0							128,000
Exercise of warrants (in shares)							0											10,000
Exercise of warrants							$ 0											$ 0							292,000						0			$ 292,000
Reclassification of warrant liabilities							$ 0											$ 0							204,398,000						0							204,398,000
Other (in shares)							(1,000)											49,000
Other							$ (6,000)											$ 0							6,000						0							0
Issuance of Common Stock in at the market offering, net (in shares)				0								1,435,000
Issuance of Common Stock in at the market offering, net				$ 0								$ 15,000										$ 13,379,000						$ 0							$ 13,394,000
Stock-based compensation expense							$ 0											$ 0							25,000						0							25,000
Balance (in shares) at Mar. 31, 2026							0											26,717,000
Balance at Mar. 31, 2026							$ 0											$ 267,000							405,209,000						(266,651,000)							138,825,000
Balance (in shares) at Dec. 31, 2025	1,347,000						1,000											25,216,000
Balance at Dec. 31, 2025	$ 350,000						$ 6,000											$ 252,000							186,981,000						(819,054,000)							(631,815,000)
Net income (loss)																																						561,696,000
Issuance of Common Stock in at the market offering, net (in shares)																																			3,854,399
Issuance of Common Stock in at the market offering, net																																$ 0
Balance (in shares) at Sep. 30, 2026							0											51,751,000
Balance at Sep. 30, 2026							$ 0											$ 518,000							439,003,000						(257,358,000)							182,163,000
Deemed capital contribution pursuant to Series F Agreements																																						0
Balance (in shares) at Mar. 31, 2026							0											26,717,000
Balance at Mar. 31, 2026							$ 0											$ 267,000							405,209,000						(266,651,000)							138,825,000
Net income (loss)							$ 0											$ 0							0						(41,070,000)							(41,070,000)
Exercise of warrants (in shares)							0											22,615,000
Exercise of warrants							$ 0											$ 226,000							24,197,000						0							24,423,000
Issuance of Common Stock in at the market offering, net (in shares)				0								1,259,000
Issuance of Common Stock in at the market offering, net				$ 0								$ 13,000										$ 1,817,000						$ 0							$ 1,830,000
Stock-based compensation expense							$ 0											$ 0							3,236,000						0							3,236,000
Balance (in shares) at Jun. 30, 2026							0											50,591,000
Balance at Jun. 30, 2026							$ 0											$ 506,000							434,459,000						(307,721,000)							127,244,000
Net income (loss)							$ 0											$ 0							0						50,363,000							50,363,000
Issuance of Common Stock in at the market offering, net (in shares)							0											1,160,000																	1,160,636
Issuance of Common Stock in at the market offering, net							$ 0											$ 12,000							1,292,000						0							1,304,000
Stock-based compensation expense							$ 0											$ 0							3,252,000						0							3,252,000
Balance (in shares) at Sep. 30, 2026							0											51,751,000
Balance at Sep. 30, 2026							$ 0											$ 518,000							$ 439,003,000						$ (257,358,000)							$ 182,163,000

[1] After giving retroactive effect to the 1-for-5 Reverse Stock Split that became effective February 20, 2026.